Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 7, 2014; 20(33): 11753-11761
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11753
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11753
Figure 5 4-hydroxynonenal immunohistostaining comparing control, non-alcoholic fatty liver disease, and osthol groups (A-D).
The NAFLD group shows increased 4-hydroxynonenal (4-HNE) immunohistostaining compared with the osthol group. NAFLD: Non-alcoholic fatty liver disease.
-
Citation: Nam HH, Jun DW, Jeon HJ, Lee JS, Saeed WK, Kim EK. Osthol attenuates hepatic steatosis
via decreased triglyceride synthesis not by insulin resistance. World J Gastroenterol 2014; 20(33): 11753-11761 - URL: https://www.wjgnet.com/1007-9327/full/v20/i33/11753.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i33.11753